JMB

eISSN 1738-8872
pISSN 1017-7825

Table. 1.

Table. 1.

Metabiotics related with microorganisms and their neurological properties.

Components Microorganism Health functional properties References
Dopamine Lactobacillus reuteri ATG-F4 Increase of cytokine IL-10 and serum dopamine level (AD) [66]
Dopamine Lactobacillus plantarum PS128 Reduction of motor dyskinesia and neurol apoptosis (PD) [69]
Dopamine Bifidobacterium bifidum,
Bifidobacterium longum,
Lactobacillus rhamnosus,
Lactobacillus rhamnosus GG,
Lactococcus lactis subsp. lactis,
Lactobacillus plantarum LP28
Protection of dopamine-releasing neurons
Decrease of motor dysfunctions
[71]
GABA Lactobacillus sp.,
Bifidobacterium sp.
Reduction of anxiety and depression (anxiety and depression) [53]
GABA Lactobacillus rhamnosus JB-1 Alleviation of anxiety and depression by decreasing corticosterone (anxiety and depression) [8]
GABA Lactobacillus rhamnosus YS9 Control nerve [57]
Histamine Lactobacillus sp.,
Lactococcus sp.,
Enterococcus sp.,
Streptococcus sp.,
Escherichia sp.
Regulation of emotions Regulation of sleep and cognitive function (cognition) [53]
Metabolites Bacteroides fragilis NCTC 9343 Reduction of autistic behavior (AD) [49]
Metabolites Bifidobacterium breve A1 Reduction of neuroinflammation (AD) [67]
SCFA Lactobacillus rhamnosus,
Lactobacillus reuteri,
Bacterioides fragilis
Regulation of anti-inflammatory pathways (AD) [53]
Serotonin Lactobacillus sp.
Lactococcus sp.,
Enterococcus sp.,
Streptococcus sp.,
Escherichia sp.
Regulation of emotions, sleep, and cognitive function (anxiety and depression, cognition) [53]

GABA, gamma-amino butyric acid; SCFAs, short-chain fatty acids; AD, Alzheimer's disease; PD, Parkinson’s disease.

J. Microbiol. Biotechnol. 2024;34:487~494 https://doi.org/10.4014/jmb.2311.11023
© J. Microbiol. Biotechnol.